ORI - Guidelines/Policies

Find a Doctor | Press Room | Careers | Directions and Locations

Ways to Give | About Us | Departments | Contact Us | Mobile

For Patients and Families Your Child's Health Clinical Services | For Health Care Professionals Medical Education Medical Research

	Office for Research Integrity
	Home Does My Project Need IRB Review? Forms Submission Deadlines and IRB Meeting Dates Guidelines/Policies Submitting Data and Samples for Researchers at Other Sites Online IRBECs Retro RRR's - IRBEC's available for completion HIPAA Requirements Truman/CMH Submission Flowchart and Information Office for Research Integrity (ORI) -- Overview and Staff Contact Us Resource Links

ORI - Guidelines/Policies

Standard Operating Procedures/Policies Relating to the Office for Research Integrity (IRB).

Requesting/Obtaining Parental Permission and Child Assent for Clinical Research

Education-Human Subjects Research.doc

Emergency Use of Investigational Drug or Biologic

Expedite-Exempt.doc

Human Subject Regulations Decision Chart.doc

(IND) Investigator Initiated Investigational New Drug Applications

NIH Policy Change on IACUC Review

NIH Release Notice: NOT-OD-02-044

Guidelines for Blood Sampling Related to Research

For all CMH Researchers: FYI - New Guidance for Investigators and Institutional Review Boards Regarding Research Involving Human Embryonic Stem Cells, Germ Cells, and Stem Cell-Derived Test Articles.
Of note are the comments regarding retention of personal identifiers on research samples and the effect on the need for IRB review. Please review at your convenience. Notice: NOT-OD-02-044

Kathy Johnson, RN, CCRC
Manager, Office for Research Integrity

CMH Employees